跳至主要内容
临床试验/DRKS00031211
DRKS00031211招募中不适用

Pharmacotherapy after bariatric surgery in primary and specialized care with special attention to drug-related problems after discharge

niversität Leipzig0 个研究点目标入组 100 人开始时间: 2023年2月14日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Bariatric surgery during the study period
  • - Written informed consent to participate in the study
  • - Sufficient language skills to participate in the study
  • - Intake of at least on peroral drug (excl. postbariatric drugs such as proton pump inhibitors, ursodeoxycholic acid and postbariatric supplements)
  • - Discharge to home

排除标准

  • - Non-fulfillment of inclusion criteria
  • - Rejection of participation by the patient or the treating physician of the study centre
  • - Discontinuation of all peroral medications after discharge

研究者

发起方
niversität Leipzig

相似试验